ORAGENICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ORAGENICS, INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $2.63M, a 43.27% increase year-over-year.
- ORAGENICS, INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $3.88M.
- ORAGENICS, INC. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $948.00K.
- ORAGENICS, INC. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $1.84M.
- ORAGENICS, INC. stock issued during period, value, new issues for fiscal 2024 was $6.67M, a 25.46% decline from fiscal 2023.
- ORAGENICS, INC. stock issued during period, value, new issues for fiscal 2023 was $8.95M.
- ORAGENICS, INC. stock issued during period, value, new issues for fiscal 2019 was $11.35M, a 651.54% increase from fiscal 2018.
- ORAGENICS, INC. stock issued during period, value, new issues for fiscal 2018 was $1.51M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-03-31 | $2.63M 10-Q · filed 2025-11-07 | |
| 2024-12-31 | $6.67M 10-K · filed 2025-03-14 | |
| 2024-09-30 | $3.88M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $948.00K 10-Q · filed 2025-11-07 | |
| 2024-03-31 | $1.84M 10-Q · filed 2025-11-07 | |
| 2023-12-31 | $8.95M 10-K · filed 2024-03-29 | |
| 2019-12-31 | $11.35M 10-K · filed 2021-03-01 | |
| 2019-06-30 | -$65.00K 10-Q · filed 2020-11-10 | |
| 2019-03-31 | $11.42M 10-Q · filed 2020-11-10 | |
| 2018-12-31 | $1.51M 10-K · filed 2020-03-04 | |
| 2016-12-31 | $2.64M 10-K · filed 2018-02-16 | |
| 2015-12-31 | $5.07M 10-K · filed 2017-02-27 | |
| 2014-12-31 | $102.50K 10-K · filed 2016-03-30 | |
| 2013-12-31 | $19.86M 10-K · filed 2015-02-27 | |
| 2012-12-31 | $27.51M 10-K · filed 2014-02-28 | |
| 2010-12-31 | $2.58M 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |